MX373380B - PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE TREATMENT OF OVERWEIGHT AND OBESITY. - Google Patents

PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE TREATMENT OF OVERWEIGHT AND OBESITY.

Info

Publication number
MX373380B
MX373380B MX2016010022A MX2016010022A MX373380B MX 373380 B MX373380 B MX 373380B MX 2016010022 A MX2016010022 A MX 2016010022A MX 2016010022 A MX2016010022 A MX 2016010022A MX 373380 B MX373380 B MX 373380B
Authority
MX
Mexico
Prior art keywords
topiramate
overweight
obesity
useful
treatment
Prior art date
Application number
MX2016010022A
Other languages
Spanish (es)
Other versions
MX2016010022A (en
Inventor
DEL VALLE LAISEQUILLA Cecilia FERNÁNDEZ
GONZÁLEZ Héctor Issac ROCHA
OCHOA Juan Antonio RAMÍREZ
García Juan Gerardo Reyes
Chávez Miguel Urbina
Original Assignee
Productos Medix S A De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Productos Medix S A De C V filed Critical Productos Medix S A De C V
Priority to MX2016010022A priority Critical patent/MX373380B/en
Publication of MX2016010022A publication Critical patent/MX2016010022A/en
Publication of MX373380B publication Critical patent/MX373380B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present disclosure is related to pharmaceutical combinations and compositions comprising therapeutically effective amounts of amfeptamone and topiramate, and its use in the preparation of drugs useful in the overweight and obesity treatment.
MX2016010022A 2016-08-02 2016-08-02 PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE TREATMENT OF OVERWEIGHT AND OBESITY. MX373380B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2016010022A MX373380B (en) 2016-08-02 2016-08-02 PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE TREATMENT OF OVERWEIGHT AND OBESITY.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2016010022A MX373380B (en) 2016-08-02 2016-08-02 PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE TREATMENT OF OVERWEIGHT AND OBESITY.

Publications (2)

Publication Number Publication Date
MX2016010022A MX2016010022A (en) 2016-11-10
MX373380B true MX373380B (en) 2020-07-02

Family

ID=58161033

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016010022A MX373380B (en) 2016-08-02 2016-08-02 PHARMACEUTICAL COMPOSITION OF AMFEPRAMONE AND TOPIRAMATE USEFUL IN THE TREATMENT OF OVERWEIGHT AND OBESITY.

Country Status (1)

Country Link
MX (1) MX373380B (en)

Also Published As

Publication number Publication date
MX2016010022A (en) 2016-11-10

Similar Documents

Publication Publication Date Title
EA201691988A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201891186A1 (en) ANTIBODIES, NEUTRALIZING THE VIRUS OF HUMAN IMMUNODEFICIENCY
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201800199A1 (en) APPLICATION OF AKKERMANSIA MUCINIPHILA FOR THE TREATMENT OF METABOLIC DISORDERS, INCREASE ENERGY CONSUMPTION AND WEIGHT REDUCTION, COMPOSITIONS, MEDICINE
MX376008B (en) EZH2 INHIBITOR FOR USE IN THE TREATMENT OF EPITHELIOID SARCOMA.
EA201690159A1 (en) METHODS AND COMPOSITIONS FOR CANCER TREATMENT
EA201691845A1 (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS
EA201692109A1 (en) OPTIONS OF ANTIBODIES TO FACTOR D AND THEIR APPLICATION
EA201692008A1 (en) SUBSTITUTED CONDENSED HETEROCYCLES AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS
EA201692007A1 (en) IZOINDOLINON COMPOUNDS AS GPR119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA, AND RELATED DISORDERS
EA201691844A1 (en) PHARMACEUTICAL COMPOSITIONS OF THERAPEUTICALLY ACTIVE COMPOUNDS
EA201692313A1 (en) Derivatives of indolysine as inhibitors of phosphosinositide-3-kinase
EA201690783A1 (en) SUBSTANCES, PHARMACEUTICAL COMPOSITION AND METHODS OF APPLICATION IN THE TREATMENT OF INFLAMMATORY DISEASES
MX2018000419A (en) Substituted amide derivatives having multimodal activity against pain.
EA201691032A1 (en) IZHOCHROMEN DERIVATIVES AS PHOSFOINOSYTID-3-KINAZ INHIBITORS
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
MY199091A (en) Therapeutic compounds
EA201890449A1 (en) FUMAGILLINUM HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND APPLICATION
MX379359B (en) DERIVATIVES OF 8-AMINO-2-OXO-1,3-DIAZA-SPIRO-[4.5]-DECane.
MX376183B (en) COMPOSITIONS FOR THE TREATMENT OF ROSACEA.
CO2020002500A2 (en) Novel acylated insulin analogs and uses of these
MX2018008640A (en) DERIVATIVES OF 3- (CARBOXIETIL) -8-AMINO-2-OXO-1,3-DIAZA-ESPIRO- [4.5] - DECANO.
MX389026B (en) A PHARMACEUTICAL COMPOSITION AND ITS USE.
MX388592B (en) COMPOUNDS AND THERAPEUTIC METHODS.
EA202090270A1 (en) NEW SUBSTITUTED Xanthine Derivatives

Legal Events

Date Code Title Description
FG Grant or registration